(Q81896223)
Statements
CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome (English)
Stefan Heinrichs
Jason N Berman
Taylor M Ortiz
Steven M Kornblau
Donna S Neuberg
A Thomas Look